Effect of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia



Status:Archived
Conditions:Schizophrenia
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Randomized, Double-blind, Placebo-controlled, Cross-over, Single-dose Study to Evaluate the Effects of AQW051 on Cognitive Function in Patients With Chronic Stable Schizophrenia Including a One Week Multiple-dose Extension to Assess the Persistence of Observed Effects


This PoC study is designed to assess the cognitive effects of doses of AQW051 in patients
with chronic stable schizophrenia.



We found this trial at
2
sites
PAREXEL (California Clinical Trials Medical Group), 1560 Chevy Chase Drive, Suite 140,
Glendale, California 91206
?
mi
from
Glendale, CA
Click here to add this to my saved trials
CRI Worldwide, LLC
Philadelphia, Pennsylvania 19139
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials